Investigation of the monocyte diapedesis-related LFA-1 and JAM-A gene variants in Turkish coronary heart disease patients.
Meta Gene
; 2: 1-10, 2014 Dec.
Article
en En
| MEDLINE
| ID: mdl-25606383
ABSTRACT
BACKGROUND:
LFA-1/JAM-A interaction plays a significant role in early steps of leukocyte transendothelial migration (diapedesis) which takes part in atherosclerosis pathogenesis. In this population-based case-control study, the frequencies of JAM-A rs790056 and LFA-1 rs8058823 gene polymorphisms in patients with coronary heart disease (CHD) and healthy subjects were investigated and the correlations between the different genotypes and cardiovascular risk factors were analyzed.METHODS:
The JAM-A and LFA-1 genotypes were determined in 153 patients with CHD and 124 controls by PCR-RFLP assay.RESULTS:
In CHD patient group, the frequency of JAM-A rs790056 TT genotype and the frequency of T allele were higher when compared with the control group (p = 0.03 and p = 0.007,respectively). In patient groups, the frequency of LFA-1 rs8058823 AA genotype was higher (p = 0.000), and the frequency of AG genotype was lower when compared with the control group (p = 0.031). In the control group, LFA-1 rs8058823 G allele carriers had higher SBP than subjects with AA genotype (p = 0.038), whereas in the CHD patient group, G allele carriers had lower DBP than subjects with AA genotype (p = 0.007). The multivariate logistic regression analysis confirmed that the JAM-A rs790056 TT genotype (OR = 2.472, p = 0.045) and LFA-1 rs8058823 AA genotype (OR = 6.751, p = 0.000) were risk factors for CHD development.CONCLUSION:
These results suggest that the wild type genotypes and alleles of JAM-A rs790056 (TT genotype and T allele) and LFA-1 rs8058823 (AA genotype and A allele) were found to be risk factors for CHD, whereas rare genotypes and alleles were found to be higher in healthy controls thus being protective.
3'UTR, 3'-untranslated region; BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; Coronary heart disease; DBP, diastolic blood pressure; Diapedesis; HDL-C, high density lipoprotein cholesterol; HWE, Hardy-Weinberg Equilibrium; JAM-A; JAM-A, junctional adhesion molecule-A; LDL-C, low density lipoprotein cholesterol; LFA-1; LFA-1, leukocyte function-associated antigen-1; LVH, left ventricular hypertrophy; OR, odds ratio; PCR-RFLP, polymerase chain reactionrestriction fragment length polymorphism; Polymorphism; SBP, systolic blood pressure; SNP, single nucleotide polymorphism; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TG, triglyceride; VLDL-C, very low density lipoprotein cholesterol
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Meta Gene
Año:
2014
Tipo del documento:
Article